Article
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
18 Aug 2023
Abstract excerpt
INTRODUCTION: Migraine, a prevalent headache disorder with unclear mechanisms and limited treatments, may be influenced by dyslipidemia and genetic factors. Statins and emerging lipid-modifying agents show potential but lack evidence for migraine management. Mendelian Randomization analysis offers insights into causal relationships and therapeutic targets. This study aims to explore genetically predicted lipid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
